Inspire Terminates Deal With FAES Farma For Oral Bilastine
Company ends collaboration following a meeting with FDA last year in which the agency recommended additional clinical trial work.
Company ends collaboration following a meeting with FDA last year in which the agency recommended additional clinical trial work.